by Eriksen Insurance | May 15, 2026 | Uncategorized
For the first time in its history, Medicare is preparing to cover weight loss drugs at scale. Beginning July 1, 2026, the new Medicare GLP-1 Bridge will give eligible Part D beneficiaries access to medications like Wegovy, Zepbound, and the newly approved Foundayo for...
by Eriksen Insurance | May 15, 2026 | Uncategorized
The Centers for Medicare and Medicaid Services refreshed its Overall Hospital Quality Star Rating this week, and the new numbers tell a familiar story. Most American hospitals are clustered in the middle of the distribution, with a small group of standouts at the top,...
by Eriksen Insurance | May 4, 2026 | Uncategorized
Medicare is about to do something it has never done before: cover prescription weight loss drugs. Starting July 1, 2026, eligible Medicare beneficiaries can get Wegovy, Zepbound, or Foundayo for just $50 a month through a new program called the Medicare GLP-1 Bridge....
by Eriksen Insurance | Apr 22, 2026 | Uncategorized
Most people already know health care is expensive, but the numbers tell a stark story. About 6 in 10 adults say they are very or somewhat worried about affording health care for themselves and their families, making it the top financial concern, ahead of food and...
by Eriksen Insurance | Apr 15, 2026 | Uncategorized
For years, the promise of GLP-1 weight loss treatment came with a catch: a weekly injection. Now, for the millions of Americans who would rather skip the needle entirely, two oral alternatives are on the market, and doctors say demand is real. Novo Nordisk’s...
